biote Corp. Statistics
Share Statistics
biote Corp. has 54.34M shares outstanding. The number of shares has increased by 59.75% in one year.
Shares Outstanding | 54.34M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -12.6% |
Owned by Institutions (%) | n/a |
Shares Floating | 49.92M |
Failed to Deliver (FTD) Shares | 4.75K |
FTD / Avg. Volume | 3.06% |
Short Selling Information
The latest short interest is 806.93K, so 1.49% of the outstanding shares have been sold short.
Short Interest | 806.93K |
Short % of Shares Out | 1.49% |
Short % of Float | 1.62% |
Short Ratio (days to cover) | 7.82 |
Valuation Ratios
The PE ratio is 38.3 and the forward PE ratio is 9.52. biote Corp.'s PEG ratio is 0.14.
PE Ratio | 38.3 |
Forward PE | 9.52 |
PS Ratio | 0.69 |
Forward PS | 1.5 |
PB Ratio | -4.32 |
P/FCF Ratio | 5.25 |
PEG Ratio | 0.14 |
Enterprise Valuation
biote Corp. has an Enterprise Value (EV) of -.
EV / Earnings | null |
EV / Sales | null |
EV / EBITDA | null |
EV / EBIT | null |
EV / FCF | null |
Financial Position
The company has a current ratio of 5.51, with a Debt / Equity ratio of -3.85.
Current Ratio | 5.51 |
Quick Ratio | 4.56 |
Debt / Equity | -3.85 |
Total Debt / Capitalization | 135.08 |
Cash Flow / Debt | 0.24 |
Interest Coverage | 4.5 |
Financial Efficiency
Return on equity (ROE) is -0.11% and return on capital (ROIC) is 834.37%.
Return on Equity (ROE) | -0.11% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 834.37% |
Revenue Per Employee | 955.46K |
Profits Per Employee | 17.09K |
Employee Count | 194 |
Asset Turnover | 1.19 |
Inventory Turnover | 2.76 |
Taxes
Income Tax | 2.68M |
Effective Tax Rate | -21.8 |
Stock Price Statistics
The stock price has increased by 24.51% in the last 52 weeks. The beta is 0.94, so biote Corp.'s price volatility has been higher than the market average.
Beta | 0.94 |
52-Week Price Change | 24.51% |
50-Day Moving Average | 5.76 |
200-Day Moving Average | 6.2 |
Relative Strength Index (RSI) | 55.45 |
Average Volume (20 Days) | 155.24K |
Income Statement
In the last 12 months, biote Corp. had revenue of $185.36M and earned $3.32M in profits. Earnings per share was $0.13.
Revenue | 185.36M |
Gross Profit | 127.48M |
Operating Income | 28.66M |
Net Income | 3.32M |
EBITDA | 9.23M |
EBIT | 28.66M |
Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has $89.00M in cash and $114.87M in debt, giving a net cash position of -$25.87M.
Cash & Cash Equivalents | 89.00M |
Total Debt | 114.87M |
Net Cash | -25.87M |
Retained Earnings | -29.39M |
Total Assets | 101.25M |
Working Capital | 23.47M |
Cash Flow
In the last 12 months, operating cash flow was $26.88M and capital expenditures -$2.71M, giving a free cash flow of $24.17M.
Operating Cash Flow | 26.88M |
Capital Expenditures | -2.71M |
Free Cash Flow | 24.17M |
FCF Per Share | 0.94 |
Margins
Gross margin is 68.78%, with operating and profit margins of 15.46% and 1.79%.
Gross Margin | 68.78% |
Operating Margin | 15.46% |
Pretax Margin | -0.07% |
Profit Margin | 1.79% |
EBITDA Margin | 4.98% |
EBIT Margin | 15.46% |
FCF Margin | 13.04% |
Dividends & Yields
BTMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.05% |
FCF Yield | 7% |
Analyst Forecast
The average price target for BTMD is $9, which is 41.7% higher than the current price. The consensus rating is "Buy".
Price Target | $9 |
Price Target Difference | 41.7% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | 1.84 |
Piotroski F-Score | 7 |